Febrivac Dist
Febrivac Dist
Authorised
- Canine distemper virus, strain Lederle D84/1, Live
Product identification
Medicine name:
Febrivac Dist
Active substance:
- Canine distemper virus, strain Lederle D84/1, Live
Target species:
-
Ferret
-
Mink
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine distemper virus, strain Lederle D84/1, Live100000.00/50% tissue culture infectious dose1.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI20CD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- IDT Biologika GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- IDT Biologika GmbH
Responsible authority:
- Paul-Ehrlich-Institut
Authorisation number:
- 12a/92
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 5/04/2022